Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Jeff Jones is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
03/26/2025 | ZURA | Buy Now | Zura Bio | $1.51 | 1158.28% | Jeff Jones33% | $20 → $19 | Maintains | Outperform | Get Alert |
03/26/2025 | CRVS | Buy Now | Corvus Pharma | $3.49 | 330.21% | Jeff Jones33% | $14 → $15 | Maintains | Outperform | Get Alert |
01/30/2025 | ALMS | Buy Now | Alumis | $4.66 | 586.7% | Jeff Jones33% | → $32 | Initiates | → Outperform | Get Alert |
01/24/2025 | EVH | Buy Now | Evolent Health | $9.45 | 90.48% | Jeff Jones33% | $28 → $18 | Maintains | Outperform | Get Alert |
12/11/2024 | CLRB | Buy Now | Cellectar Biosciences | $0.36 | — | Jeff Jones33% | — | Downgrade | Outperform → Perform | Get Alert |
11/22/2024 | CATX | Buy Now | Perspective Therapeutics | $2.24 | 614.29% | Jeff Jones33% | $22 → $16 | Maintains | Outperform | Get Alert |
11/19/2024 | CLRB | Buy Now | Cellectar Biosciences | $0.36 | 3204.87% | Jeff Jones33% | $14 → $12 | Maintains | Outperform | Get Alert |
11/18/2024 | EVH | Buy Now | Evolent Health | $9.45 | 196.3% | Jeff Jones33% | $34 → $28 | Maintains | Outperform | Get Alert |
11/18/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.84 | 375.21% | Jeff Jones33% | → $23 | Initiates | → Outperform | Get Alert |
11/15/2024 | CMMB | Buy Now | Chemomab Therapeutics | $1.15 | 856.52% | Jeff Jones33% | $13 → $11 | Reiterates | Outperform → Outperform | Get Alert |
11/13/2024 | CRVS | Buy Now | Corvus Pharma | $3.49 | 301.53% | Jeff Jones33% | $8 → $14 | Reiterates | Outperform → Outperform | Get Alert |
11/08/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.23 | 631.71% | Jeff Jones33% | $10 → $9 | Reiterates | Outperform → Outperform | Get Alert |
11/08/2024 | EVH | Buy Now | Evolent Health | $9.45 | 259.79% | Jeff Jones33% | $45 → $34 | Maintains | Outperform | Get Alert |
10/11/2024 | CLRB | Buy Now | Cellectar Biosciences | $0.36 | 3755.69% | Jeff Jones33% | $14 → $14 | Reiterates | Outperform → Outperform | Get Alert |
10/11/2024 | CATX | Buy Now | Perspective Therapeutics | $2.24 | 882.14% | Jeff Jones33% | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert |
09/27/2024 | KYMR | Buy Now | Kymera Therapeutics | $30.39 | 84.27% | Jeff Jones33% | $52 → $56 | Maintains | Outperform | Get Alert |
09/10/2024 | AVBP | Buy Now | ArriVent BioPharma | $18.28 | 113.35% | Jeff Jones33% | $35 → $39 | Reiterates | Outperform → Outperform | Get Alert |
08/15/2024 | AVBP | Buy Now | ArriVent BioPharma | $18.28 | 91.47% | Jeff Jones33% | $35 → $35 | Reiterates | Outperform → Outperform | Get Alert |
08/13/2024 | CATX | Buy Now | Perspective Therapeutics | $2.24 | 658.93% | Jeff Jones33% | $19 → $17 | Maintains | Outperform | Get Alert |
08/09/2024 | IMCR | Buy Now | Immunocore Hldgs | $29.47 | 202% | Jeff Jones33% | $87 → $89 | Reiterates | Outperform → Outperform | Get Alert |
08/08/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.48 | 2940.54% | Jeff Jones33% | $48 → $45 | Maintains | Outperform | Get Alert |
08/07/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $5.92 | 1386.49% | Jeff Jones33% | $80 → $88 | Maintains | Outperform | Get Alert |
07/10/2024 | KYMR | Buy Now | Kymera Therapeutics | $30.39 | 71.11% | Jeff Jones33% | $52 → $52 | Maintains | Outperform | Get Alert |
07/10/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $5.92 | 1251.35% | Jeff Jones33% | $80 → $80 | Reiterates | Outperform → Outperform | Get Alert |
06/18/2024 | CATX | Buy Now | Perspective Therapeutics | $2.24 | — | Jeff Jones33% | $2 → $19 | Reiterates | Outperform → Outperform | Get Alert |
06/07/2024 | MCRB | Buy Now | Seres Therapeutics | $0.71 | — | Jeff Jones33% | — | Downgrade | Outperform → Perform | Get Alert |
06/06/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.23 | 713.01% | Jeff Jones33% | $12 → $10 | Maintains | Outperform | Get Alert |
06/03/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $5.92 | 1251.35% | Jeff Jones33% | $60 → $80 | Maintains | Outperform | Get Alert |
05/10/2024 | ZURA | Buy Now | Zura Bio | $1.51 | 1290.73% | Jeff Jones33% | $16 → $21 | Maintains | Outperform | Get Alert |
05/09/2024 | MCRB | Buy Now | Seres Therapeutics | $0.71 | 462.83% | Jeff Jones33% | $5 → $4 | Maintains | Outperform | Get Alert |
05/08/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $5.92 | 913.51% | Jeff Jones33% | $58 → $60 | Maintains | Outperform | Get Alert |
05/07/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.48 | 3143.24% | Jeff Jones33% | $47 → $48 | Reiterates | Outperform → Outperform | Get Alert |
05/07/2024 | CRVS | Buy Now | Corvus Pharma | $3.49 | 129.44% | Jeff Jones33% | $7 → $8 | Maintains | Outperform | Get Alert |
05/06/2024 | CMMB | Buy Now | Chemomab Therapeutics | $1.15 | 421.74% | Jeff Jones33% | → $6 | Upgrade | Perform → Outperform | Get Alert |
05/03/2024 | KYMR | Buy Now | Kymera Therapeutics | $30.39 | 71.11% | Jeff Jones33% | $53 → $52 | Maintains | Outperform | Get Alert |
04/22/2024 | KYMR | Buy Now | Kymera Therapeutics | $30.39 | 74.4% | Jeff Jones33% | → $53 | Initiates | → Outperform | Get Alert |
04/01/2024 | ZURA | Buy Now | Zura Bio | $1.51 | 959.6% | Jeff Jones33% | $17 → $16 | Reiterates | Outperform → Outperform | Get Alert |
04/01/2024 | CATX | Buy Now | Perspective Therapeutics | $2.24 | -33.04% | Jeff Jones33% | $12 → $15 | Reiterates | Outperform → Outperform | Get Alert |
04/01/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.52 | — | Jeff Jones33% | — | Reiterates | Perform → Perform | Get Alert |
03/28/2024 | CLRB | Buy Now | Cellectar Biosciences | $0.36 | 3204.87% | Jeff Jones33% | $11 → $12 | Reiterates | Outperform → Outperform | Get Alert |
03/20/2024 | CRVS | Buy Now | Corvus Pharma | $3.49 | 100.76% | Jeff Jones33% | $8 → $7 | Maintains | Outperform | Get Alert |
03/19/2024 | CATX | Buy Now | Perspective Therapeutics | $2.24 | -46.43% | Jeff Jones33% | $12 → $12 | Reiterates | Outperform → Outperform | Get Alert |
03/13/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $5.92 | 879.73% | Jeff Jones33% | $51 → $58 | Reiterates | Outperform → Outperform | Get Alert |
03/12/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.23 | 875.61% | Jeff Jones33% | → $12 | Upgrade | Perform → Outperform | Get Alert |
03/08/2024 | CMMB | Buy Now | Chemomab Therapeutics | $1.15 | — | Jeff Jones33% | — | Maintains | Perform | Get Alert |
03/06/2024 | MCRB | Buy Now | Seres Therapeutics | $0.71 | 603.53% | Jeff Jones33% | $9 → $5 | Maintains | Outperform | Get Alert |
03/01/2024 | EVH | Buy Now | Evolent Health | $9.45 | 376.19% | Jeff Jones33% | → $45 | Initiates | → Outperform | Get Alert |
02/29/2024 | PDCO | Buy Now | Patterson Cos | $31.24 | -3.97% | Jeff Jones33% | $32 → $30 | Maintains | Neutral | Get Alert |
02/21/2024 | VTYX | Buy Now | Ventyx Biosciences | $1.23 | — | Jeff Jones33% | — | Reiterates | → Perform | Get Alert |
02/12/2024 | ANTX | Buy Now | AN2 Therapeutics | $1.52 | — | Jeff Jones33% | — | Downgrade | Outperform → Perform | Get Alert |
01/29/2024 | CRBP | Buy Now | Corbus Pharmaceuticals | $5.92 | 761.49% | Jeff Jones33% | $20 → $51 | Maintains | Outperform | Get Alert |
01/16/2024 | MCRB | Buy Now | Seres Therapeutics | $0.71 | 1166.36% | Jeff Jones33% | $10 → $9 | Maintains | Outperform | Get Alert |
01/05/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Jeff Jones33% | $13 → $15 | Maintains | Outperform | Get Alert |
12/27/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Jeff Jones33% | $13 → $13 | Reiterates | Outperform → Outperform | Get Alert |
11/30/2023 | PDCO | Buy Now | Patterson Cos | $31.24 | 2.43% | Jeff Jones33% | $35 → $32 | Maintains | Neutral | Get Alert |
09/29/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Jeff Jones33% | → $13 | Initiates | → Outperform | Get Alert |
08/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.48 | 3413.51% | Jeff Jones33% | $51 → $52 | Maintains | Outperform | Get Alert |
08/09/2023 | CRBP | Buy Now | Corbus Pharmaceuticals | $5.92 | 271.62% | Jeff Jones33% | → $22 | Reiterates | Outperform → Outperform | Get Alert |
07/05/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.23 | 4940.65% | Jeff Jones33% | $62 → $62 | Reiterates | Outperform → Outperform | Get Alert |
06/22/2023 | PDCO | Buy Now | Patterson Cos | $31.24 | 12.04% | Jeff Jones33% | $31 → $35 | Maintains | Neutral | Get Alert |
06/07/2023 | CMMB | Buy Now | Chemomab Therapeutics | $1.15 | — | Jeff Jones33% | — | Downgrade | Outperform → Perform | Get Alert |
06/01/2023 | NOVN | Buy Now | Novan | — | — | Jeff Jones33% | — | Downgrade | Outperform → Perform | Get Alert |
05/25/2023 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $0.31 | 2489.83% | Jeff Jones33% | → $120 | Maintains | Outperform | Get Alert |
05/23/2023 | RAIN | Buy Now | Rain Oncology | $1.95 | — | Jeff Jones33% | — | Downgrade | Outperform → Perform | Get Alert |
05/19/2023 | CATX | Buy Now | Perspective Therapeutics | $2.24 | -46.43% | Jeff Jones33% | $10 → $12 | Maintains | Outperform | Get Alert |
05/16/2023 | PNT | Buy Now | POINT Biopharma Global | — | — | Jeff Jones33% | → $13 | Reiterates | Outperform → Outperform | Get Alert |
05/16/2023 | NOVN | Buy Now | Novan | — | — | Jeff Jones33% | $9 → $8 | Maintains | Outperform | Get Alert |
05/11/2023 | PMVP | Buy Now | PMV Pharma | $1.16 | 1193.1% | Jeff Jones33% | → $15 | Reiterates | Outperform → Outperform | Get Alert |
05/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.48 | 3345.95% | Jeff Jones33% | $44 → $51 | Maintains | Outperform | Get Alert |
05/10/2023 | CRBP | Buy Now | Corbus Pharmaceuticals | $5.92 | 271.62% | Jeff Jones33% | → $22 | Upgrade | Perform → Outperform | Get Alert |
04/18/2023 | CMMB | Buy Now | Chemomab Therapeutics | $1.15 | 508.7% | Jeff Jones33% | $12 → $7 | Maintains | Outperform | Get Alert |
03/30/2023 | ANTX | Buy Now | AN2 Therapeutics | $1.52 | 1478.95% | Jeff Jones33% | $20 → $24 | Maintains | Outperform | Get Alert |
03/24/2023 | MBRX | Buy Now | Moleculin Biotech | $1.06 | 371.65% | Jeff Jones33% | → $75 | Reiterates | → Outperform | Get Alert |
03/24/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.23 | 4940.65% | Jeff Jones33% | $65 → $62 | Maintains | Outperform | Get Alert |
03/10/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.48 | 2872.97% | Jeff Jones33% | $43 → $44 | Maintains | Outperform | Get Alert |
03/07/2023 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $0.31 | 2489.83% | Jeff Jones33% | $150 → $120 | Maintains | Outperform | Get Alert |
03/02/2023 | PMVP | Buy Now | PMV Pharma | $1.16 | 1193.1% | Jeff Jones33% | $28 → $15 | Maintains | Outperform | Get Alert |
03/01/2023 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones33% | $125 → $150 | Maintains | Outperform | Get Alert |
01/27/2023 | VTYX | Buy Now | Ventyx Biosciences | $1.23 | 4778.05% | Jeff Jones33% | $55 → $60 | Maintains | Outperform | Get Alert |
12/08/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones33% | $61 → $125 | Maintains | Outperform | Get Alert |
11/17/2022 | EVAX | Buy Now | Evaxion Biotech | $1.70 | 547.06% | Jeff Jones33% | $1600 → $1100 | Maintains | Outperform | Get Alert |
10/11/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | Jeff Jones33% | → $20 | Initiates | → Outperform | Get Alert |
10/04/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones33% | $50 → $65 | Maintains | Outperform | Get Alert |
09/12/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.23 | 5184.55% | Jeff Jones33% | $40 → $65 | Maintains | Outperform | Get Alert |
08/16/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.23 | 3152.03% | Jeff Jones33% | $30 → $40 | Maintains | Outperform | Get Alert |
07/19/2022 | NOVN | Buy Now | Novan | — | — | Jeff Jones33% | → $12 | Initiates | → Outperform | Get Alert |
07/18/2022 | CLRB | Buy Now | Cellectar Biosciences | $0.36 | 1414.73% | Jeff Jones33% | → $55 | Assumes | → Outperform | Get Alert |
07/18/2022 | CYCC | Buy Now | Cyclacel Pharmaceuticals | $0.31 | 5403.4% | Jeff Jones33% | → $255 | Assumes | → Outperform | Get Alert |
07/18/2022 | EVAX | Buy Now | Evaxion Biotech | $1.70 | 841.18% | Jeff Jones33% | → $1600 | Assumes | → Outperform | Get Alert |
07/18/2022 | MBRX | Buy Now | Moleculin Biotech | $1.06 | 1220.63% | Jeff Jones33% | $30 → $210 | Assumes | → Outperform | Get Alert |
07/18/2022 | VBLT | Buy Now | Vascular Biogenics | — | — | Jeff Jones33% | → $192.5 | Assumes | → Outperform | Get Alert |
06/09/2022 | PMVP | Buy Now | PMV Pharma | $1.16 | 2744.83% | Jeff Jones33% | $30 → $33 | Maintains | Outperform | Get Alert |
04/01/2022 | RAIN | Buy Now | Rain Oncology | $1.95 | 669.23% | Jeff Jones33% | → $15 | Initiates | → Outperform | Get Alert |
03/10/2022 | CMMB | Buy Now | Chemomab Therapeutics | $1.15 | 1639.13% | Jeff Jones33% | $30 → $20 | Maintains | Outperform | Get Alert |
03/02/2022 | PMVP | Buy Now | PMV Pharma | $1.16 | — | Jeff Jones33% | — | Upgrade | Perform → Outperform | Get Alert |
02/01/2022 | VTYX | Buy Now | Ventyx Biosciences | $1.23 | 2339.02% | Jeff Jones33% | → $30 | Initiates | → Outperform | Get Alert |
12/10/2021 | PLRX | Buy Now | Pliant Therapeutics | $1.48 | 2602.7% | Jeff Jones33% | → $40 | Initiates | → Outperform | Get Alert |
12/08/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones33% | $35 → $50 | Upgrade | Perform → Outperform | Get Alert |
11/15/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones33% | — | Downgrade | Outperform → Perform | Get Alert |
10/05/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Jeff Jones33% | → $35 | Initiates | → Outperform | Get Alert |
08/19/2021 | PMVP | Buy Now | PMV Pharma | $1.16 | — | Jeff Jones33% | — | Initiates | → Perform | Get Alert |
05/07/2021 | CMMB | Buy Now | Chemomab Therapeutics | $1.15 | 3552.17% | Jeff Jones33% | → $42 | Initiates | → Outperform | Get Alert |